Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Operating Leases (2020 - 2025)

Historic Operating Leases for Evotec SE (EVO) over the last 3 years, with Q4 2022 value amounting to $165.3 million.

  • Evotec SE's Operating Leases rose 626.15% to $165.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $165.3 million, marking a year-over-year increase of 626.15%. This contributed to the annual value of $165.3 million for FY2022, which is 626.15% up from last year.
  • As of Q4 2022, Evotec SE's Operating Leases stood at $165.3 million, which was up 626.15% from $152459.2 recorded in Q3 2022.
  • In the past 5 years, Evotec SE's Operating Leases registered a high of $165.3 million during Q4 2022, and its lowest value of -$152437.6 during Q2 2022.
  • Moreover, its 3-year median value for Operating Leases was $159158.7 (2022), whereas its average is $68.2 million.
  • The largest annual percentage gain for Evotec SE's Operating Leases in the last 5 years was 626.15% (2022), contrasted with its biggest fall of 303.92% (2022).
  • Evotec SE's Operating Leases (Quarter) stood at $156.1 million in 2020, then dropped by 0.37% to $155.5 million in 2021, then rose by 6.26% to $165.3 million in 2022.
  • Its Operating Leases stands at $165.3 million for Q4 2022, versus $152459.2 for Q3 2022 and -$152437.6 for Q2 2022.